We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

21 hedge funds and large institutions have $1.24M invested in Tenax Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

119% more capital inflows, than outflows

Capital inflows: $158K | Capital outflows: $72.1K

31% more funds holding

Funds holding: 16 → 21 (+5)

1.41% more ownership

Funds ownership: 27.49% → 28.9% (+1.4%)

Holders
21
Holders Change
+5
Holders Change %
+31.25%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
4
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Armistice Capital
Armistice Capital
New York
+$92.7K
2
Renaissance Technologies
Renaissance Technologies
New York
+$19.3K
3
Millennium Management
Millennium Management
New York
+$16.9K
4
Virtu Financial
Virtu Financial
New York
+$5.22K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.82K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$46.1K
2
Citadel Advisors
Citadel Advisors
Florida
-$22K
3
Citigroup
Citigroup
New York
-$4K

TENX Hedge Fund Activity: Q3 2022 in Review

21 of the 5,832 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2022, worth a combined $1.24M — down 41% from $2.08M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new TENX positions and 2 closed out — a net gain of 5 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Armistice Capital, adding an estimated $92.7K. The largest seller was Vanguard Group, cutting an estimated $46.1K.

  • 21 institutional investors held Tenax Therapeutics (TENX) as of Q3 2022, up from 16 in Q2 2022.
  • Funds reported $1.24M of Tenax Therapeutics stock for Q3 2022, down 41% quarter-over-quarter.
  • 7 funds opened new Tenax Therapeutics positions in Q3 2022 and 2 closed out, a net change of +5 holders.
  • The largest Tenax Therapeutics buyer in Q3 2022 was Armistice Capital, an estimated $92.7K added.
  • The largest Tenax Therapeutics seller in Q3 2022 was Vanguard Group, an estimated $46.1K sold.

Based on aggregated 13F filings for Q3 2022.